Resultaten visas 1 - 10 / 13144
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Dry Eye Disease - Nordic Guidelines 2016

Öppen tillgång
Heegaard S, Knudsen LL, van Setten G, Koranyi G, Holopainen J, Kaarniranta K, Klyve P, Raeder S
-2016

Impact of signs and symptoms of dry eye disease on health-related quality of life: a cross-sectional population study among older adults

Referentgranskad
Öppen tillgång
DOI
10.1007/s11136-025-03907-0
Aapola, Ulla; Mosallaei, Paula; Nättinen, Janika; Suurkuukka, Ilona; Tuomilehto, Jaakko; Keinänen-Ki...
Quality of life research2025

Relevance of Lipid-Based Products in the Management of Dry Eye Disease

Referentgranskad
Öppen tillgång
DOI
10.1089/jop.2017.0052
Garrigue, Jean-Sebastien; Amrane, Mourad; Faure, Marie-Odile; Holopainen, Juha M.; Tong, Louis
Journal of ocular pharmacology and therapeutics2017

Two middle-aged women with the Finnish variant of muscle-eye-brain disease (MEB)

Referentgranskad
Öppen tillgång
DOI
10.1002/ajmg.a.61369
Arvio, Maria; Määttänen, Laura; Haanpää, Maria ; Lähdetie, Jaana
American journal of medical genetics. Part A2019

Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment

Referentgranskad
Öppen tillgång
DOI
10.18632/aging.102118
Wilcockson, Thomas D. W.; Mardanbegi, Diako; Xia, Baiqiang; Taylor, Simon; Sawyer, Pete; Gellersen, ...
Aging2019

Kuivana lastuaminen (Dry Cutting)

Referentgranskad
Kauppinen, V.
Tribologia1995

Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors

Referentgranskad
Öppen tillgång
Gushansky, Konstantin Y.; Tuuminen, Raimo
Molecular Vision2024

Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors

Referentgranskad
Öppen tillgång
Gushansky, Konstantin Y.; Tuuminen, Raimo
Molecular Vision2024

Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial

Referentgranskad
Öppen tillgång
Laihia J; Järvinen R; Wylegala E; Kaarniranta K
Acta Ophthalmologica2020

Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial

Referentgranskad
Öppen tillgång
DOI
10.1111/aos.14252
Laihia, J; Järvinen, R; Wylegala, E; Kaarniranta, K
Acta ophthalmologica2019

Dry Eye Disease - Nordic Guidelines 2016

Öppen tillgång
2016

Impact of signs and symptoms of dry eye disease on health-related quality of life: a cross-sectional population study among older adults

Referentgranskad
Öppen tillgång
DOI
10.1007/s11136-025-03907-0
2025

Relevance of Lipid-Based Products in the Management of Dry Eye Disease

Referentgranskad
Öppen tillgång
DOI
10.1089/jop.2017.0052
2017

Two middle-aged women with the Finnish variant of muscle-eye-brain disease (MEB)

Referentgranskad
Öppen tillgång
DOI
10.1002/ajmg.a.61369
2019

Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment

Referentgranskad
Öppen tillgång
DOI
10.18632/aging.102118
2019

Kuivana lastuaminen (Dry Cutting)

Referentgranskad
1995

Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors

Referentgranskad
Öppen tillgång
2024

Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors

Referentgranskad
Öppen tillgång
2024

Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial

Referentgranskad
Öppen tillgång
2020

Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial

Referentgranskad
Öppen tillgång
DOI
10.1111/aos.14252
2019